Publications by authors named "Kayla Fourzali"

Claim this Profile
M
Mapping Online Discourse on Topical Steroid Withdrawal: Accuracy, Safety, and Supporting Evidence.
Joyce J Zhu, Annabel Hou, Jillian Baader, Zoe Lipman, Kayla Fourzali

Cureus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous infection in an immunocompetent patient.
Shaliz Aflatooni, Alison H Kucharik, Kayla M Fourzali, Leslie Turner, Catherine Kowalewski

JAAD Case Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Approach to Hypereosinophilic Syndrome Presenting With Cutaneous Features.
Kayla Fourzali, Gil Yosipovitch, Andrea Maderal

Dermatitis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipruritic Effect of Topical Acetaminophen Gel in Histaminergic and Non-histaminergic Itch Provocation: A Double-blind, Vehicle-controlled Pilot Study.
Leigh A Nattkemper, Kaining Zhi, Kaeli E Romero, Serena M Shah, Teresa Ju, Kayla Fourzali

Acta Derm Venereol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the ACMG/NSGC genetic referral guidelines for hereditary renal cell carcinoma at the University of Miami, from 2014 to 2017.
Jessica D Leuchter, Priyen M Patel, Kayla M Fourzali, Talia R Donenberg, Rachel Silva-Smith

Am J Med Genet A· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Gene Expression in Primates with Itch.
Leigh A Nattkemper, Kayla Fourzali, Gil Yosipovitch

J Invest Dermatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab use in atopic dermatitis and beyond in skin diseases.
Kayla Fourzali, Rachel Shireen Golpanian, Gil Yosipovitch

Immunotherapy· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging drugs for the treatment of chronic pruritic diseases.
Kayla Fourzali, Rachel Shireen Golpanian, Gil Yosipovitch

Expert Opin Emerg Drugs· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pleasurability of Scratching an Itch Amongst Different Pruritic Conditions.
Rachel Shireen Golpanian, Kayla Fourzali, Emilie Fowler, Christina Dorothy Kursewicz, Zoe Lipman

Acta Derm Venereol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatric Comorbidities in Non-psychogenic Chronic Itch, a US-based Study.
Rachel Shireen Golpanian, Zoe Lipman, Kayla Fourzali, Emilie Fowler, Leigh A Nattkemper

Acta Derm Venereol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety considerations when using drugs to treat pruritus.
Kayla Fourzali, Gil Yosipovitch

Expert Opin Drug Saf· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Itch in the Elderly: A Review.
Kayla M Fourzali, Gil Yosipovitch

Dermatol Ther (Heidelb)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis